These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27121545)

  • 21. A screening assessment of cognitive impairment in patients with ALS.
    Gordon PH; Wang Y; Doorish C; Lewis M; Battista V; Mitsumoto H; Marder K
    Amyotroph Lateral Scler; 2007 Dec; 8(6):362-5. PubMed ID: 17852014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic variability in ALS-FTD and effect on survival.
    Ahmed RM; Devenney EM; Strikwerda-Brown C; Hodges JR; Piguet O; Kiernan MC
    Neurology; 2020 May; 94(19):e2005-e2013. PubMed ID: 32277059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis.
    Lillo P; Garcin B; Hornberger M; Bak TH; Hodges JR
    Arch Neurol; 2010 Jul; 67(7):826-30. PubMed ID: 20625088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive-behavioral changes in amyotrophic lateral sclerosis: Screening prevalence and impact on patients and caregivers.
    Bock M; Duong YN; Kim A; Allen I; Murphy J; Lomen-Hoerth C
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):366-73. PubMed ID: 27043386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semantic deficits in amyotrophic lateral sclerosis.
    Leslie FV; Hsieh S; Caga J; Savage SA; Mioshi E; Hornberger M; Kiernan MC; Hodges JR; Burrell JR
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):46-53. PubMed ID: 25544644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The frontotemporal syndrome of ALS is associated with poor survival.
    Govaarts R; Beeldman E; Kampelmacher MJ; van Tol MJ; van den Berg LH; van der Kooi AJ; Wijkstra PJ; Zijnen-Suyker M; Cobben NA; Schmand BA; de Haan RJ; de Visser M; Raaphorst J
    J Neurol; 2016 Dec; 263(12):2476-2483. PubMed ID: 27671483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A visual MRI atrophy rating scale for the amyotrophic lateral sclerosis-frontotemporal dementia continuum.
    Ambikairajah A; Devenney E; Flanagan E; Yew B; Mioshi E; Kiernan MC; Hodges JR; Hornberger M
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):226-34. PubMed ID: 24533506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Amyotrophic Lateral Sclerosis and Frontotemporal Dementia].
    Watanabe Y
    Brain Nerve; 2019 Nov; 71(11):1227-1235. PubMed ID: 31722308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frontal assessment battery to evaluate frontal lobe dysfunction in ALS patients.
    Ahn SW; Kim SH; Kim JE; Kim SM; Kim SH; Sung JJ; Lee KW; Hong YH
    Can J Neurol Sci; 2011 Mar; 38(2):242-6. PubMed ID: 21320827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive and behavioral status in Japanese ALS patients: a multicenter study.
    Watanabe Y; Raaphorst J; Izumi Y; Yoshino H; Ito S; Adachi T; Takigawa H; Masuda M; Atsuta N; Adachi Y; Isose S; Arai K; Yokota O; Oda M; Ogino M; Ichikawa H; Hasegawa K; Kimura H; Shimizu T; Aiba I; Yabe H; Kanba M; Kusumi K; Aoki T; Hiroe Y; Watanabe H; Nishiyama K; Nomoto M; Sobue G; Beeldman E; Hanajima R; Nakashima K;
    J Neurol; 2020 May; 267(5):1321-1330. PubMed ID: 31955246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population.
    Lulé D; Burkhardt C; Abdulla S; Böhm S; Kollewe K; Uttner I; Abrahams S; Bak TH; Petri S; Weber M; Ludolph AC
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Mar; 16(1-2):16-23. PubMed ID: 25292386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS.
    Poletti B; Carelli L; Solca F; Lafronza A; Pedroli E; Faini A; Ticozzi N; Ciammola A; Meriggi P; Cipresso P; Lulé D; Ludolph AC; Riva G; Silani V
    J Neurol; 2017 Jun; 264(6):1136-1145. PubMed ID: 28503706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis.
    Lepow L; Van Sweringen J; Strutt AM; Jawaid A; MacAdam C; Harati Y; Schulz PE; York MK
    J Clin Exp Neuropsychol; 2010 Nov; 32(9):913-22. PubMed ID: 20390792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcultural validation of the ALS-CBS Cognitive Section for the Brazilian population.
    Branco LM; Zanao T; De Rezende TJ; Casseb RF; Balthazar MF; Woolley SC; França MC
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):60-67. PubMed ID: 27534257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods.
    Simon N; Goldstein LH
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):1-11. PubMed ID: 30585510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival.
    Ahmed RM; Caga J; Devenney E; Hsieh S; Bartley L; Highton-Williamson E; Ramsey E; Zoing M; Halliday GM; Piguet O; Hodges JR; Kiernan MC
    J Neurol; 2016 Aug; 263(8):1593-603. PubMed ID: 27260291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic coherence between hereditary amyotrophic lateral sclerosis and frontotemporal dementia].
    Gjerde KV; Tysnes OB
    Tidsskr Nor Laegeforen; 2014 Feb; 134(3):302-6. PubMed ID: 24518478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice.
    Gosselt IK; Nijboer TCW; Van Es MA
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):324-336. PubMed ID: 32157912
    [No Abstract]   [Full Text] [Related]  

  • 39. Factors Affecting Performance on a Screening Tool in Persons with Amyotrophic Lateral Sclerosis.
    Stierwalt J; Stierwalt JAG; Clark H; Burda A; Benavidez Kiley H; Collins E; Kortemeyer M; Miller E; Peckenschneider G; Schieltz E; Shah Y; Simon K
    Semin Speech Lang; 2024 Jun; 45(3):228-241. PubMed ID: 38565200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Evolution of Caregiver Burden in Frontotemporal Dementia with and without Amyotrophic Lateral Sclerosis.
    Hsieh S; Leyton CE; Caga J; Flanagan E; Kaizik C; O'Connor CM; Kiernan MC; Hodges JR; Piguet O; Mioshi E
    J Alzheimers Dis; 2016; 49(3):875-85. PubMed ID: 26519438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.